[177Lu]Lu-AKIR001 First-in-human Study

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Thyroid Gland Anaplastic Carcinoma · Poorly Differentiated Thyroid Carcinoma · Cancer Head and Neck · Cervix Carcinoma · Vulvar Cancer, Stage IV · Non-small Cell Lung Cancer Stage IV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Karolinska University hospital, Stockholm, Stockholm County, Sweden
Contact: Study coordinator (Johanna Uggla, research nurse) · johanna.uggla@regionstockholm.se

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

BRAF NP_004324.2:p.V600E · BRAF V600K Mutation Present · Thyroid Gland Anaplastic Carcinoma

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Columbus, United States

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Renal Cell Carcinoma (RCC) · Lung Cancer · Anaplastic Thyroid Carcinomas

Abroad (travel likely)RecruitingPHASE1

Hefei, China

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Advanced Thyroid Carcinoma · Radioiodine-refractory Differentiated Thyroid Cancer · Poorly Differentiated Thyroid Carcinoma

Abroad (travel likely)Recruiting

Hangzhou, China